Dr. Susan E. Spiller
Claim this profileEast Tennessee Childrens Hospital
Expert in Tumors
Expert in Brain Tumor
46 reported clinical trials
99 drugs studied
About Susan E. Spiller
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Pediatrics at East Tennessee Children's Hospital.
- Achieved Board Certification in Pediatrics by the American Board of Pediatrics.
Experience:
- Currently serves as a pediatrician at East Tennessee Children's Hospital, offering comprehensive care to children and adolescents.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Susan E. Spiller is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Susan E. Spiller
Clinical Trial Related7 years of experience running clinical trials · Led 46 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Susan E. Spiller has experience with
- Cyclophosphamide
- Radiation Therapy
- Nivolumab
- Doxorubicin Hydrochloride
- Cisplatin
- Etoposide
Breakdown of trials Susan E. Spiller has run
Tumors
Brain Tumor
Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan E. Spiller specialize in?
Susan E. Spiller focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Susan E. Spiller currently recruiting for clinical trials?
Yes, Susan E. Spiller is currently recruiting for 16 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Susan E. Spiller has studied deeply?
Yes, Susan E. Spiller has studied treatments such as Cyclophosphamide, Radiation Therapy, Nivolumab.
What is the best way to schedule an appointment with Susan E. Spiller?
Apply for one of the trials that Susan E. Spiller is conducting.
What is the office address of Susan E. Spiller?
The office of Susan E. Spiller is located at: East Tennessee Childrens Hospital, Knoxville, Tennessee 37916 United States. This is the address for their practice at the East Tennessee Childrens Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.